Format

Send to

Choose Destination
Health Rep. 2010 Jun;21(2):37-42.

The Manitoba human papillomavirus vaccine surveillance and evaluation system.

Author information

1
CancerCare Manitoba, Winnipeg, Manitoba. Erich.Kliewer@cancercare.mb.ca

Erratum in

  • Health Rep. 2010 Sep;21(3):77.

Abstract

BACKGROUND:

With the recent introduction of a human papillomavirus (HPV) vaccine in Canada, it is important to establish surveillance and evaluation programs that not only track the uptake of the vaccine, but also assess its safety and its impact on: distribution of HPV type, cervical cancer screening programs, the incidence of anogenital warts, precancerous lesions and various cancers, and sexual behaviour.

DATA SOURCES AND METHODS:

Administrative databases, registries and questionnaire information are being linked to identify people receiving the HPV vaccine and to develop an evaluation system.

INTERPRETATION:

The availability of extensive linkable databases in Manitoba allows for the development of a comprehensive HPV vaccine surveillance and evaluation system that can address many of the questions related to the HPV vaccine. Aspects of the Manitoba surveillance and evaluation system could be implemented in other provinces that have similar databases.

PMID:
20632523
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Statistics Canada-Health Analysis Division
Loading ...
Support Center